StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.38−0.22 (-2.29%)

Close on Nov 18, 2026Market cap $620.70MP/E –Yield –

Bicara Therapeutics cash

Cash and short-term investments held at the end of each period.

Bicara Therapeutics's cash was $442.35M at Sep 30, 2026. For fiscal 2025 it was $414.80M, down 15.3% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$414.80M-15.3%
FY2024Dec 31, 2024$489.71M+112.5%
FY2023Dec 31, 2023$230.44M+5442.1%
FY2022Dec 31, 2022$4.16M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$442.35M+52.4%
Q2 FY2026Jun 30, 2026$497.26M+13.9%
Q1 FY2026Mar 31, 2026$539.75M+16.8%
Q4 FY2025Dec 31, 2025$414.80M-15.3%
Q3 FY2025Sep 30, 2025$290.17M-44.3%
Q2 FY2025Jun 30, 2025$436.61M+114.2%
Q1 FY2025Mar 31, 2025$462.07M+113.9%
Q4 FY2024Dec 31, 2024$489.71M+112.5%
Q3 FY2024Sep 30, 2024$520.76M+1077.9%
Q2 FY2024Jun 30, 2024$203.86M+4802.7%
Q1 FY2024Mar 31, 2024$216.05M–
Q4 FY2023Dec 31, 2023$230.44M–
Q3 FY2023Sep 30, 2023$44.21M–
Q4 FY2022Dec 31, 2022$4.16M–

More Bicara Therapeutics figures

See a number that looks wrong?